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Abstract
Background: The MacNew health-related quality of life questionnaire was designed to assess 
feelings about how heart disease affects their daily physical, emotional and social functioning in 
patients with 1 of the 3 major coronary artery diagnoses, stable coronary artery disease (CAD) 
with angina, ST-elevation myocardial infarction (STEMI), and ischemic heart failure (HF).  
The aim of this study was to determine the reliability and validity of the Polish version of the 
MacNew in patients with CAD.
Methods: Patients with CAD completed a self-report sociodemographic and clinical ques-
tionnaire: the MacNew, the Short-Form 36 Health Survey, and HADS at baseline; 10% of the 
patients completed each questionnaire 2 weeks later.
Results: We studied patients with stable CAD with angina (n = 115), with STEMI (n = 112),  
and with ischemic HF (n = 105). Internal consistency reliability was demonstrated with Cron-
bach’s a from 0.86 to 0.95 for the MacNew global scale and subscales. The original 3-factor 
structure was confirmed for the Polish version of the MacNew explaining 53.5% of the vari-
ance. Convergent validity of similar MacNew and SF-36 subscales was confirmed in the total 
group and in each diagnosis. Discriminant validity with the SF-36 health transition was fully 
confirmed in the total group and in patients with HF and partially confirmed in patients with 
stable CAD with angina or myocardial infarction.
Conclusions: The Polish MacNew health-related quality of life questionnaire can be recom-
mended in patients with stable CAD with angina, myocardial infarction and HF. (Cardiol J 
2015; 22, 5: 541–550)
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Introduction
One of the more important developments in 
health care in the past decade or two may be the 
recognition that the patients’ perspective is as 
legitimate and valid as the clinician’s in monitor-
ing health status and health care outcomes [1–4]. 
There are several disease-specific health-related 
quality of life (HRQL) inventories for patients 
with the 3 major coronary artery disease (CAD) 
diagnoses — stable CAD with angina [5], myocar-
dial infarction (MI) [6] and heart failure (HF) [7]. 
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Disease-specific questionnaires are more relevant 
and so more sensitive than generic HRQL ques-
tionnaires but do not allow between-diagnosis 
comparisons suggesting the potential need for 
a single core CAD-specific questionnaire to cover 
the 3 major CAD diagnoses [8].
The MacNew HRQL questionnaire was de-
signed to assess patients’ feelings about how heart 
disease affects daily functioning and contains 27 
items with a global HRQL score and physical limita-
tion, emotional, and social function subscales [6]. 
As part of the international HeartQoL Project con-
ducted in 22 different countries [9], the MacNew 
was translated into Polish using forward-backward 
translation [10]. The MacNew HRQL has been 
translated also into 38 languages and all translated 
and validated versions of MacNew can be accessed 
at MacNew.org [11].
The aim of this study was to determine the 
reliability and validity of the Polish version of the 
MacNew in patients with CAD for both researchers 
and practitioners in Poland to monitor the effective-
ness of different treatments or the same treatment 
in the 3 major CAD diagnoses.
Methods
Subjects
A convenience sample of 332 patients with 
angina (n = 115), ST elevation MI (STEMI) (n = 112), 
or with ischemic HF (n = 105) was recruited from 
the Department of Cardiology, Medical University 
of Gdansk and the 3 cardiac rehabilitation units of 
the Health Clinic: “Leśnik” and “Helios” in Sopot 
as well as “Neptun” in Wieżyca. We recruited pa-
tients who were being treated for current typical 
chest pain based on positive non-invasive testing 
(exercise testing, stress echo, or nuclear imag-
ing) and/or positive invasive testing (coronary 
angiography); patients with MI were recruited 
4 weeks to 6 months after a documented STEMI; 
and patients with ischemic HF were recruit-
ed based on a left ventricular ejection fraction 
< 40% (diagnosed on base of echo or left heart 
catheterization) and angina (documented previous 
Ml, exercise testing, stress echo. nuclear imaging 
or angiography). Patients also had to be at least 
18 years old, have no major psychiatric disorders, 
no present substance abuse and were able to com-
plete the Polish-language questionnaires.
The Medical Ethics Committee of the Medical 
University of Gdansk approved the study protocols. 
Subjects were given the opportunity to not partici-
pate in the study or resign at any stage.
Patients-reported outcome assessment
A doctor referred patients to the HeartQoL 
Project and provided the patient’s routine diagnostic 
and clinical data. All patients completed a self-report 
sociodemographic and clinical questionnaire. The 
MacNew [6], the Short-Form 36 Health Survey 
(SF-36) [12], and Hospital Anxiety and Depression 
Scale (HADS) [13] were completed at baseline by all 
patients and again 2 weeks later by approximately 
10% of patients for testing instrument test-retest 
reliability. The questionnaires were completed a few 
days after admission to the Department of Cardiol-
ogy or cardiac rehabilitation unit.
MacNew HRQL
The MacNew questionnaire is a 27-item self-
administered questionnaire with a global scale 
and a physical, emotional and social subscale. The 
MacNew has a 2-week timeframe and is designed 
to assess patient’s feelings about how CAD af-
fects daily functioning with each item scored from 
1 (low HRQL) to 7 (high HRQL) [6, 14]. A score 
is generated for each of the physical, emotional 
and social MacNew subscales as the mean of the 
number of subscale items with a response; the 
MacNew global score is the sum of the score on 
all scored items divided by the number of scored 
items. The MacNew was translated into Polish 
using the linguistic validation forward-backward 
translation technique [10].
Short Form-36
The Short-Form SF-36 is a valid health survey 
consisting of 36 items consisting of two scales, 
a physical component summary (PCS), and a mental 
component summary (MCS) [12]. Raw scores are 
summed and then transformed to a 0–100 scale. 
The SF-36 questionnaire is widely used in patients 
with CAD and is available in Polish [15].
Hospital Anxiety and Depression Scale
The HADS is an extensively used 14-item 
psychological screening instrument designed to 
detect symptoms of anxiety and depression [13]. 
A score of 8 or more indicates symptoms of either 
depression or anxiety [16] and the Polish version 
of the HADS has been validated [17].
Statistical analysis
Patient clinical and sociodemographic charac-
teristics are described as either dichotomous (%) 
or continuous variables (mean ± standard devia-
tion). Analysis of variance (ANOVA) was used to 
examine differences and change in outcome data.
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Floor and ceiling effects
Floor effects occurred when patients scored at 
the lowest MacNew HRQL score, i.e., 1, and ceiling 
effects occurred at the highest HRQL score, i.e., 7. 
The presence of floor effects indicates instrument 
sensitivity in detecting worsening health status 
while ceiling effects indicate sensitivity in detect-
ing significant health improvements [18].
Reliability
The reliability of the MacNew was evaluated by 
examining its internal consistency (Cronbach’s a); 
test-retest reliability (14-day) was assessed in 
a subsample of approximately 10% patients with 
the intraclass correlation coefficient (ICC) where 
a value of ≥ 0.70 is considered acceptable for group 
comparisons [19].
Validity
To assess convergent validity, we compared 
the ICC between the corresponding MacNew 
and SF-36 scales (Pearson ICC < 0.10 — absent, 
0.10–0.30 — weak, 0.30–0.49 — moderate and 
≥ 0.50 — strong) hypothesizing strong correlations 
between similar constructs, i.e., the SF-36 Health 
Survey PCS and MCS and the corresponding 
MacNew scale constructs, and significantly lower 
correlations between dissimilar constructs [20, 
21]. To assess discriminative validity, we used the 
“known groups” approach [18] hypothesizing that 
A) patients who report improvement or no change 
on the SF-36 health transition item would have 
better HRQL than patients who reported deterio-
rated health and B) and that patients who showed 
symptoms of anxiety or depression on the HADS 
(HADS cut-off scores, ≥ 8) would have poorer 
HRQL than those patients without symptoms of 
anxiety or depression.
Results
Sociodemographic and clinical data (Table 1)
Baseline sociodemographic and clinical data 
were collected in all 332 patients and detailed 
characteristics are presented in Table 1. The 
mean age of all patients was 60.2 ± 10.1 years, the 
majority of patients were men (74.4%) and there 
were no statistically significant differences in the 
gender distribution between the clinical groups. 
Patients with HF were approximately 5 years 
older than patients with MI or angina. Patients 
with higher education were most likely to be in 
the angina group while the largest proportion of 
patients with primary education had HF. Statisti-
cally significant differences were observed by 
education between the groups with HF and MI. 
Patients with MI were more likely to be smokers 
than patients with either angina or HF (p = 0.012). 
Patients with angina were more likely to report 
that their doctor told them they had hyperten-
sion than patients with MI or HF (p < 0.01) 
and were more likely to report having hypercho-
lesterolemia than patients with HF (p < 0.01). 
Patients with angina were more likely to engage in 
regular physical exercise than patients with either 
MI or HF (p = 0.001).
Health-related quality of life scores (Table 2)
The mean MacNew scores ranged from 4.5 on 
the physical subscale, to 4.8 on the global scale, to 
4.9 on the social subscale and to 5.0 on the emo-
tional subscale in the total group. Patients with 
MI had significantly higher scores on the MacNew 
global scale and each subscale than patients with 
either angina or HF (p < 0.001).
The mean PCS score was 37.5 with a mean 
MCS score of 45.8 in the total group. Patients 
with MI had significantly higher PCS scores than 
patients with either angina or HF (p < 0.001) with 
no between-diagnosis differences on the MCS.
The mean HADS anxiety score was 7.4 with 
a mean HADS depression score of 6.1 in the total 
group. Patients with MI had significantly lower 
(p < 0.05) HADS anxiety scores than patients with 
angina and significantly lower (p < 0.05) HADS 
depression scores than patients with HF.
MacNew questionnaire item  
characteristics (Table 3)
There were no MacNew floor effects in the 
total group or by diagnosis. There were no MacNew 
ceiling effects in patients with angina; however, 
ceiling effects occurred in ≤ 1.2% of the total 
group, in ≤ 1.8% of patients with MI and in ≤ 1.9% 
of patients with HF.
Psychometric analysis
MacNew reliability (Table 3). Internal 
consistency reliability. Cronbach’s a ranged 
from 0.94 (global scale), to 0.91 (physical and emo-
tional subscales), and 0.90 (social subscale) in the 
total group. By diagnosis, Cronbach’s a ranged from 
a high of 0.92 on the physical subscale in patients 
with HF and on emotional subscale in patients 
with angina to a low of 0.86 on the physical 
subscale in patients with angina. Test-retest 
reliability. The 14-day ICCs for global scale and 
subscales were significant (p < 0.01) in the total 
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group (n = 31) and each diagnosis even though the 
sample sizes were small (angina, and MI, n = 12 
each; HF, n = 7).
MacNew exploratory factor analysis (Table 4)
The original 3-factor structure for the Pol-
ish version was largely confirmed (with loadings 
≥ 0.40) explaining 53.5% of the variance (emotional 
subscale, 21.7%; physical subscale, 19.7%; social 
subscale, 12.1%). Eight items partially conformed 
to the original factor structure; 2 of the 14 emo-
tional subscale items, 1 of the 13 the physical sub-
scale items, and 5 of the 14 social subscale items.
MacNew convergent validity (Table 5)
The a priori convergent hypotheses for strong 
correlations, i.e., r ≥ 0.50, between corresponding 
MacNew and SF-36 constructs and lower correla-
tions between dissimilar constructs were confirmed. 
All correlations between the corresponding MacNew 
and SF-36 constructs, i.e., MacNew physical subscale 
and SF-36 PCS, MacNew emotional subscale and 
SF-36 MCS, were both strong and significant. The 
correlations between dissimilar MacNew and SF-36 
constructs, although ≥ 0.50 on the emotional subscale 
in the total group and in patients with MI, were sig-
nificantly lower than for the similar constructs.
MacNew discriminative validity (Table 6)
Using the SF-36 health transition item, Mac-
New scores in patients with angina, MI, or HF 
whose health either improved or stayed the same 
were not significantly different and so the data 
from the two groups were combined. Patients 
in the total group and patients with HF whose 
health either improved or stayed the same had 
higher MacNew scores on the global scale and 
each subscale when compared to patients whose 
Table 1. Sociodemographic and clinical characteristics (mean ± standard deviation; or %) of the total 
group of patients and by diagnosis (stable coronary artery disease with angina [Angina], myocardial 
infarction [MI] and heart failure [HF]); data missing when total < 100%.
Patient  
characteristics
Total group  
(n = 332)
Angina  
(n = 115)
MI  
(n =112)
HF  
(n = 105)
P
Age [year] 60.2 ± 10.1 58.4 ± 8.6 59.1 ± 10.4 63.4 ± 10.5 < 0.001b,c
Gender:
Male 74.4% 71.3% 71.4% 81.0% 0.20
Female 25.6% 28.7% 28.6% 19.0%
Family status:
Single 15.4% 12.2% 17.0% 17.1% 0.94
Married 75.3% 82.6% 70.5% 72.4%
Other 9.3% 5.2% 12.5% 10.5%
Employment:
White collar 44.6% 49.6% 45.5% 38.1% 0.22
Blue collar 55.4% 50.4% 54.5% 61.9%
Education:
Primary 40.7% 33.0% 39.3% 50.5% 0.04b
Secondary 40.1% 43.5% 43.8% 32.4%
Higher: 19.3% 23.5% 17.0% 17.1%
Anxious [HADS ≥ 8] 45.2% 51.3% 57.1% 41.0% 0.24
Depressed [HADS ≥ 8] 31.3% 33.9% 23.2% 37.1% 0.07
Body mass index 28.0 ± 4.4 29.1 ± 4.1 27.6 ± 3.9 27.2 ± 4.9 0.003a
Smoker 25.9% 21.7% 35.7% 20.0% 0.012a,b
Hypertensive 59.9% 73.0% 56.3% 49.5% 0.01a, c
Diabetic 23.2% 25.2% 16.1% 28.6% 0.06
Hypercholesterolemia 55.7% 65.2% 56.3% 44.8% 0.01c
Physically inactive* 54.5% 68.7% 46.4% 47.6% 0.001a, c
*< 3 times/week; aangina vs. MI; bHF vs. MI; cHF vs. angina; HADS — Hospital Anxiety and Depression Scale
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health had deteriorated (p < 0.001). Patients with 
angina whose health either improved or stayed 
the same had higher MacNew scores only on the 
social subscale when compared to patients whose 
health had deteriorated (p = 0.03). Patients with 
MI whose health either improved or stayed the 
same had higher MacNew scores on the physical 
subscale (p < 0.001) and on the global scale and 
the social subscale (p = 0.01) than patients whose 
health had deteriorated. With both HADS anxiety 
and depression, patients in the total group and each 
diagnosis without anxiety or depression symptoms 
Table 2. Mean MacNew, SF36 physical component scale (PCS) and mental component scale (MCS) and 
Hospital and Anxiety Scale (HADS) scores ± standard deviation in the total group and by diagnosis 
(stable coronary artery disease with angina [angina], myocardial infarction [MI] and heart failure [HF]). 
Total group Angina MI HF P
MacNew Global 4.8 ± 1.0 4.6 ± 0.8 5.3 ± 0.9 4.6 ± 1.0 < 0.001a,b
Physical 4.5 ± 1.2 4.3± 0.9 5.1 ± 1.1 4.1± 1.2 < 0.001a,b
Emotional 5.0 ± 1.0 4.8 ± 0.9 5.4 ± 1.0 4.9 ± 1.0 < 0.001a,b
Social 4.9 ± 1.1 4.8 ± 1.0 5.4 ± 1.1 4.6 ± 1.1 < 0.001a,b
SF-36 PCS 37 5 ± 10.3 35.2 ± 8.5 42.7 ± 9.8 34.3± 10.4 < 0.001a,b
MCS 45.8 ± 10.0 45 1 ± 10.6 47.8 ± 9.0 45 8 ± 10.3 0.45
HADS Anxiety 7.4 ± 3.7 8.0 ± 3.6 6.8 ± 3.5 7.2 ± 4.1 < 0.05a
Depression 6.1 ± 3.6 6.2 ± 3.5 5.3 ± 3.5 6.8 ± 3.7 < 0.01b
aMI vs. angina; bMI vs. HF
Table 3. MacNew global and subscale floor and ceiling effects, internal consistency (Cronbach’s a) and 
test-retest reliability (n = 126) in the total group and by diagnosis (stable coronary artery disease with 
angina, myocardial infarction [MI] and heart failure [HF]).
MacNew
Global Physical Emotional Social
Total group
% Floor 0% 0% 0% 0%
% Ceiling 0% 0.6% 0.3% 1.2%
Cronbach’s a 0.94 0.91 0.91 0.90
rtt (n = 31) 0.98* 0.98* 0.98* 0.98*
Angina
% Floor 0% 0% 0% 0%
% Ceiling 0% 0% 0% 0%
Cronbach’s a 0.93 0.86 0.91 0.89
rtt (n = 12) 0.99* 0.98* 0.99* 0.99*
MI
% Floor 0% 0% 0% 0%
% Ceiling 0% 1.8% 0% 1.8%
Cronbach’s a 0.92 0.89 0.92 0.90
rtt (n = 12) 0.96* 0.94* 0.97* 0.95*
HF
% Floor 0% 0% 0% 0%
% Ceiling 0% 0% 1% 1.9%
Cronbach’s a 0.95 0.92 0.91 0.89
rtt (n = 7) 0.98* 0.97* 0.97* 0.98*
*p < 0.01
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had higher MacNew scores on the global scale 
and each subscale than patients with symptoms 
(p < 0.001).
Discussion
The Polish version of the MacNew in 332 pa- 
tients with angina, MI, or HF demonstrated sat-
isfactory psychometric properties. The original 
3-factor structure for the Polish version was 
largely confirmed. Internal consistency reliabil-
ity was always ≥ 0.86 and test-retest reliability 
always significant and ≥ 0.94 in the total group 
and each diagnosis. All correlations between the 
corresponding MacNew and SF-36 constructs 
were both strong and significant with significantly 
lower correlations between dissimilar constructs. 
Discriminative validity was fully demonstrated on 
the SF-36 health transition item in the total group 
and in patients with HF although only partially 
confirmed in patients with either angina or MI. 
Discriminative validity was also fully demonstrated 
with both HADS anxiety and depression. In addi-
tion, the MacNew is well rated by patients as being 
user-friendly with the instructions easy to follow, 
the questions understandable and relevant to pa-
tients’ problems and is completed in approximately 
10 min. Consistent with other language reports on 
the MacNew [22–25], the Polish MacNew can be 
considered a potential CAD-specific core HRQL 
questionnaire allowing across-diagnosis compari-
sons with one HRQL questionnaire.
Table 4. Principal component analysis: factor loadings ≥ 0.40 for each MacNew item in the total group.  
Loadings < 0.40 are not displayed and items with asterisk (*) do not conform fully to the original factor 
analysis. 
Emotional 
domain (E)
Physical 
domain (P)
Social 
domain (S)
Original MacNew domain
1.    Frustrated 0.72 E
2.    Worthless* 0.66 E S
3.    Confident 0.40 E
4.    Down in the dumps 0.79 E
5.    Relaxed 0.67 E
6.    Worn out 0.63 0.52 E P
7.    Happy with personal life 0.64 E
8.    Restless 0.71 E
9.    Shortness of breath 0.71 P
10.  Tearful 0.68 E
11.  More dependent 0.57 S
12.  Social activities* 0.52 0.44 E P S
13.  Less confidence in you*   0.62 E S
14.  Chest pain 0.52 P
15.  Lack self-confidence* 0.57 E S
16.  Aching legs 0.58 P
17.  Sports/exercise limited* 0.75 P S
18.  Frightened 0.64 E
19.  Dizzy or lightheaded 0.47 P
20.  Restricted or limited* 0.74 P S
21.  Unsure about exercise* 0.55 P S
22.  Overprotective family 0.67 S
23.  Burden on others 0.42 0.60 E S
24.  Excluded 0.61 0.49 P S
25.  Unable to socialize 0.61 0.49 P S
26.  Physically restricted* 0.78 P S
27.  Sexual activity 0.46 0.42 P S
Variance explained [%] 21.7% 19.7% 12.1%
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Table 5. Convergent validity of the MacNew physical and emotional subscales with the Short Form-36 
physical component scale (PCS) and mental component scale (MCS) in the total group and by diagnosis; 
strong correlations bolded.
MacNew physical subscale MacNew emotional subscale P (1-sided)*
Total group (n = 332):
SF-36 PCS 0.72 0.50 < 0.001
SF-36 MCS 0.43 0.71 < 0.001
P (1-sided)* < 0.001 < 0.001
Angina (n = 115):
SF-36 PCS 0.63 0.36 < 0.001
SF-36 MCS 0.47 0.73 < 0.001
P (1-sided)* < 0.05 < 0.001
Myocardial infarction (n = 112):
SF-36 PCS 0.77 0.51 < 0.001
SF-36 MCS 0.45 0.71 < 0.01
P (1-sided)* < 0.001 < 0.001
Heart failure (n = 105):
SF-36 PCS 0.72 0.49 < 0.001
SF-36 MCS 0.42 0.71 < 0.001
P (1-sided)* < 0.001 < 0.01
*Steiger’s test for comparing Pearson correlation coefficients; P-values for all correlations < 0.001
Consistent with MacNew publications in other 
languages, patients with MI had significantly bet-
ter HRQL than patients with either angina or 
HF [24–26]. Also consistent with other MacNew 
publications, there were no MacNew floor effects 
and ceiling effects were observed in < 2.0% of all 
patients [24, 25]. With floor and ceiling effects of 
1% to 15% considered small [27], the MacNew 
clearly is responsive both to HRQL deterioration 
and improvement in each diagnostic group.
The statistical analysis of the Polish version 
of MacNew was carried out according to the in-
ternational criteria and recommended procedure 
for psychometric analysis [19]. Factor analysis ex-
plained 53.5% of the total variance which is similar 
to results obtained in other languages versions of 
MacNew in a sample of patients with angina, MI 
and HF [26, 28–30]. Nineteen of the 27 MacNew 
items (70%) loaded consistently with the original 
MacNew 3-factor structure [6]. The emotional 
subscale, with one item, and the physical subscale, 
with 2 items, loaded most consistently with the 
original 3-factor structure. However, 5 of the so-
cial subscale items did not load with the original 
structure of the social scale which is consistent 
with similar proportions in other languages, e.g., 
German [14, 30, 31] and Portuguese [29]. The 
sexual activity item (#27) falls into the physical 
and social subscales in this report; however, this 
item was not included in the original factor analysis 
and has recently been shown to fall into the social 
rather than the physical subscale [22, 29]. The 
original factor structure of the MacNew allowed 
items with loadings of ≥ 0.40 to load on more than 
one subscale which is of concern [32, 33] and is 
being investigated with other analytic approaches.
The Polish MacNew demonstrated good inter-
nal consistency reliability with Cronbach’s a always 
≥ 0.86 with test-retest reliability always ≥ 0.94 for 
the global scale and each subscale in the total group 
and each diagnosis. There is relatively consistent 
evidence for Polish MacNew’s construct validity 
with convergent validity confirmed in part with 
strong correlations as predicted between similar 
MacNew and SF-36 constructs. However, some 
of the correlations between dissimilar constructs 
(e.g., MacNew physical and SF-36 MCS scales) 
were higher than expected which has also been 
observed in previous studies [25, 29]. This may 
be related to the way the MacNew probes were 
originally developed with the focus on the patient’s 
perceptions of the difficulties with physical activi-
ties rather than on physical performance as in the 
SF-36 [29].
As there were no significant differences be-
tween the “improved health” and “stayed the same 
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Table 6. Discriminant validity of MacNew global score and subscale scores (mean ± standard devia-
tion) by SF-36 health status transition and Hospital Anxiety and Depression Scale (HADS) anxiety and 
depression in the total group and by diagnosis (stable coronary artery disease with angina (angina), 
myocardial infarction and [MI] heart failure [HF]).
MacNew
Global Physical Emotional Social
Total group
SF-36 health transition: 
Improve/no change 5.2 ± 0.9 5.0 ± 1.2 5.4 ± 0.8 5.4 ± 1.0
Deteriorate 4.6 ± 1.0 4.2 ± 1.1 4.9 ± 1.1 4.7 ± 1.1
P < 0.001 < 0.001 < 0.001 < 0.001
Anxiety:
No 5.2 ± 0.8 4.8 ± 1.1 5.5 ± 0.7 5.2 ± 1.0
Yes 4.3 ± 1.0 4.1 ± 1.1 4.5 ± 1.0 4.5 ± 1.1
P < 0.001 < 0.001 < 0.001 < 0.001
Depression:
No 5.1 ± 0.8 4.8 ± 1.1 5.4 ± 0.8 5.2 ± 1.0
Yes 4.1 ± 0.9 3.9 ± 1.1 4.3 ± 1.0 4.2 ± 1.1
P < 0.001 < 0.001 < 0.001 < 0.001
Angina
SF-36 health transition:
Improve/no change 4.9 ± 0.8 4.5 ± 1.1 5.1 ± 0.8 5.1 ± 0.9
Deteriorate 4.5 ± 0.9 4.2 ± 0.9 4.7 ± 0.9 4.6 ± 1.0
P 0.06 0.09 0.06 0.03
Anxiety:
No 5.1 ± 0.7 4.7 ± 0.9 5.4 ± 0.7 5.2 ± 0.8
Yes 4.2 ± 0.8 4.0 ± 0.8 4.3 ± 0.8 4.4 ± 0.9
P < 0.001 < 0.001 < 0.001 < 0.001
Depression: 
No 4.9 ± 0.7 4.6 ± 0.9 5.2 ± 0.8 5.1 ± 0.8
Yes 4.0 ± 0.8 3.8 ± 0.9 4.1 ± 0.8 4.2 ± 0.9
P < 0.001 < 0.001 < 0.001 < 0.001
Myocardial infarction
SF-36 health transition:
Improve/no change 5.6 ± 0.8 5.7 ± 1.0 5.6 ± 0.8 5.8 ± 0.9
Deteriorate 5.0 ± 1.0 4.8 ± 1.1 5.2 ± 1.0 5.1 ± 1.1
P 0.01 < 0.001 0.2 0.01
Anxiety:
No 5.6 ± 0.7 5.4 ± 1.0 5.7 ± 0.7 5.6 ± 0.9
Yes 4.9 ± 1.1 4.7 ± 1.2 4.9 ± 1.1 5.0 ± 1.2
P < 0.001 < 0.001 < 0.001 < 0.01
Depression:
No 4.9 ± 1.0 4.4 ± 1.3 5.3 ± 0.9 5.0 ± 1.1
Yes 4.0 ± 0.9 3.6 ± 0.9 4.3 ± 1.0 4.0 ± 1.0
P < 0.001 < 0.001 < 0.001 < 0.001
Heart failure
SF-36 health transition:
Improve/no change 5.1 ± 0.9 4.7 ± 1.2 5.4 ± 0.8 5.2 ± 1.0
Deteriorate 4.2 ± 1.0 3.7 ± 1.0 4.6 ± 1.1 4.2 ± 1.1 
P < 0.001 < 0.001 < 0.001 < 0.001
Anxiety:
No 4.9 ± 0.9 4.3 ± 1.3 5.3 ± 0.8 4.9 ± 1.1
Yes 4.1 ± 1.0 3.7 ± 1.0 4.3 ± 1.0 4.2 ± 1.1
P < 0.001 < 0.01 < 0.001 < 0.01
Depression:
No 4.9 ± 1.0 4.4 ± 1.3 5.3 ± 0.9 5.0 ± 1.1
Yes 4.0 ± 0.9 3.6 ± 0.9 4.3 ± 1.0 4.0 ± 1.0
P < 0.001 < 0.001 < 0.001 < 0.001
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health” groups, we combined the two groups and 
compared the MacNew scores for the combined 
group and the deteriorated health group. Discrimi-
native validity was fully demonstrated with signifi-
cantly lower HRQL scores in the total group and 
in patients with HF, largely confirmed in patients 
with MI, but only partially confirmed in patients 
with angina when compared to those whose health 
improved or stayed the same. From a clinical rather 
than statistical perspective, the minimal important 
difference (MID) on the MacNew is 0.5 points 
[34]. Norman et al. [35] have suggested that “in 
most circumstances, the threshold of discrimina-
tion for changes in health-related quality of life 
for chronic diseases appears to be approximately 
half a standard deviation”. The standard deviation 
of the baseline global MacNew score in the total 
cohort is 1.0 in the present study which supports 
the earlier observation of an MID of 0.5 points on 
the MacNew [34]. All MacNew score differences 
between those whose health had deteriorated and 
those who improved or stayed the same met or 
exceeded the MID in the total group and in patients 
with HF; in patients with MI, the MID was met or 
exceeded on the global scale and the physical and 
social subscales; in patients with MI, the MID was 
met only on the social subscale. Discriminative 
validity was fully confirmed with HADS anxiety 
and depression symptoms in the total group and in 
each diagnosis and patients without HADS anxiety 
and depression symptoms had significantly bet-
ter HRQL than patients with HADS anxiety and 
depression.
As the parent HeartQoL Project was an in-
ternational cross-sectional survey of HRQL [9], 
demonstration of the responsiveness in the Polish 
MacNew was not possible. This needs to be investi-
gated in a prospective study in Polish patients with 
CAD before a full recommendation of the Polish 
MacNew as a core CAD-specific HRQL question-
naire can be made.
Conclusions
The Polish version of the MacNew HRQL 
questionnaire appears to be both reliable and valid, 
demonstrating satisfactory psychometric proper-
ties in this Polish sample of patients with CAD. The 
Polish MacNew can be recommended for assessing 
and evaluating HRQL for patients suffering from 
angina or HF and following MI in clinical studies.
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